Fibronostics

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics HealthFACTR tool employes technology to predict risk, providing results for risks of coronary...

Liver,liver health,liver disease,nafld,artificial intelligence,machine learning,non invasive ,nash,and med tech

Fibronostics operates in the Hospitals and health care industry.

Fibronostics's revenue is 11m - 100m

Fibronostics has 11 - 50 employees.